Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
, education or training in a related field Prior experience coordinating clinical trials or research studies involving stem cell therapies. Prior experience in a clinical setting, with at least one year of
-
University of Texas Health Science Center San Antonio | San Antonio, Texas | United States | about 14 hours ago
stem cell biology. In addition to clinical and academic departments, UTHSA is enriched by the Nathan Shock Center for Excellence in Biology of Aging, an NCI-designated Cancer Center, an NIH-funded
-
Assistant/Associate/Full Professor of Surgery – Genome Editing Delivery Expert UCSF Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research (Broad Center) Department of Surgery
-
biology, developmental biology, epigenetic mechanisms and molecular biological techniques, accompanied by demonstrated bioinformatic skills. Experience culturing trophoblast stem cells would be an asset
-
environmental and hormonal control of plant stem cell differentiation. You should be proficient in bulk and single-cell RNA-seq, ChIP-seq, and/or ATAC-seq analyses and standard bioinformatics pipelines
-
Control of Inflammation” in International Review of Cell and Molecular Biology (Elsevier, 2018; https://linkinghub.elsevier.com/retrieve/pii/S1937644817300825)vol. 335, pp. 41–84. What are the signals
-
blood stem cells (e.g. Frömel et al., Cell 2025 ), and more translational projects in the context of acute myeloid leukemia (AML) and pre-leukemia (e.g. Beneyto-Calabuig et al., Cell Stem Cell 2023
-
high quality research, training and mentorship to excellent and ambitious students interested in cancer research, including- but not limited to- its intersection with stem cell biology, immunity
-
Employer https://main.hercjobs.org/jobs/21969649/clinical-assistant-hematopoietic-stem-cell-transplant Return to Search Results
-
preclinical (basic science and translational) studies into optimizing the safety and efficacy of hematopoietic stem cell transplantation for hematologic diseases, with emphasis on definitive therapies for non